Integrated technology platform for accelerated discovery of antiviral antibody therapeutics

Pavlo Gilchuk(Vanderbilt University Medical Center), Robert H. Carnahan(Vanderbilt University Medical Center), Qing Tan(Alvin J. Siteman Cancer Center), Lorellin A. Durnell(Washington University in St. Louis), Neal Van Hoeven(Sana Biotechnology (United States)), Jesse H. Erasmus(University of Washington), Thomas Broge(Ragon Institute of MGH, MIT and Harvard), Larissa B. Thackray(Washington University in St. Louis), Peter Abbink(Beth Israel Deaconess Medical Center), James E. Crowe(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Matthew J. Gorman(Ragon Institute of MGH, MIT and Harvard), Dan H. Barouch(Beth Israel Deaconess Medical Center), Caitlyn Linde, Robin Bombardi(Vanderbilt University Medical Center), Edgar Davidson(Integral Molecular (United States)), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Cinque Soto(National Institutes of Health), Benjamin J. Doranz(Integral Molecular (United States)), Jacob Archer(Infectious Disease Research Institute), Vicky Roy(Ragon Institute of MGH, MIT and Harvard), Steven G. Reed(Infectious Disease Research Institute), Michael Diamond(Washington University in St. Louis), Amit P. Khandhar(LodeSpin Labs (United States)), Taylor Jones(Vanderbilt University Medical Center), Elise Larson(Infectious Disease Research Institute), Todd J. Suscovich, Thomas C. Linnekin(Ragon Institute of MGH, MIT and Harvard), Mallorie E. Fouch(Integral Molecular (United States)), Joseph P. Nkolola(Beth Israel Deaconess Medical Center), Jenny Liang(Integral Molecular (United States)), Stacey Ertel(Infectious Disease Research Institute), Brian Granger(Infectious Disease Research Institute), Jasmine Fuerte-Stone(Infectious Disease Research Institute)
bioRxiv (Cold Spring Harbor Laboratory)
May 14, 2020
Cited by 3


Related Papers